Posted On: 09/01/2014 6:08:49 PM
Post# of 95
Not much action on ONVO here... but found this link...
from another site back in the spring...
ONVO SA article from earlier: ONVO: "Organovo is planning on launching the 3D liver product in December 2014. If it receives a positive response from the KOL, as it most likely will, this product is expected to generate solid revenue streams in the years to come. Analysts estimate this revenue to be around $15 million in 2014. Moreover, with the launch of the liver product for clinical trials the company can set foot in the $7 billion preclinical research service market. The company anticipates that preclinical toxicology testing services can command prices in excess of tens of thousands of dollars per compound. Hence, the launch of its first product is a promising sign in its future growth."
http://seekingalpha.com/article/2014361-organ...urce=yahoo
and then today's brutal SA bash.
http://seekingalpha.com/article/2077693-best-...urce=yahoo
Amazing stuff.
from another site back in the spring...
ONVO SA article from earlier: ONVO: "Organovo is planning on launching the 3D liver product in December 2014. If it receives a positive response from the KOL, as it most likely will, this product is expected to generate solid revenue streams in the years to come. Analysts estimate this revenue to be around $15 million in 2014. Moreover, with the launch of the liver product for clinical trials the company can set foot in the $7 billion preclinical research service market. The company anticipates that preclinical toxicology testing services can command prices in excess of tens of thousands of dollars per compound. Hence, the launch of its first product is a promising sign in its future growth."
http://seekingalpha.com/article/2014361-organ...urce=yahoo
and then today's brutal SA bash.
http://seekingalpha.com/article/2077693-best-...urce=yahoo
Amazing stuff.
(0)
(0)
